Sang-Moon Han, PhD. CHA University
Introduction: Sleeve gastrectomy (SG) is the leading weight loss procedure for treating morbid obesity. However, mid-term results of the isolated SG which was performed in lower body mass index (BMI) (30-35) are sparse.
Methods and procedures: We retrospectively reviewed 69 patients who underwent SG in class 1 obesity (30-35 kg/m2) from January 2013 to December 2016. SG was performed laparoscopically using Endo-GIA stapler to create a lesser curve gastric tube over a 36-Fr bougie, and continuous sero-serosal suture at resection margin has been added.
Results: The age before surgery was 35.3 ± 8.1. The mean weight and body mass index (BMI) before LSG were 87.9 ± 9.3 kg and 32.2 ± 1.5 kg/m2. The BMI at first, second, and third year postoperatively was 22.2 ± 2.3, 23.3 ± 2.6, and 23.8 ± 2.7. The percentage of excess BMI loss (cut-off BMI: 23) at postoperative first, second and third year was 109.7 ± 26.3, 97.1 ± 29.1, and 90.1 ± 30.0. However, the follow up rate is decreased by postoperative time. There was no 30-day peri-operative mortality and major complications including bleeding and leakage.
Conclusion: These finding show that SG is a very effective and safe weight loss option for class 1 obesity. However, proper weight loss concept after SG should be reconsidered to improve health in class 1 obesity. Also, randomized prospective control study between gastric banding and SG, or gastric bypass and SG are needed to confirm long-term weight loss effect and safety of SG in class 1 obesity.
Presented at the SAGES 2017 Annual Meeting in Houston, TX.
Abstract ID: 86219
Program Number: P655
Presentation Session: iPoster Session (Non CME)
Presentation Type: Poster